EUSA Pharma Inc.'s FDA approval of acute lymphoblastic leukemia (ALL) drug Erwinaze (asparaginase Erwinia chrysanthemi) means the privately held specialty pharma firm may now be poised for an exit. Read More
WASHINGTON – Citing a lack of proof that the benefits outweigh the risks, FDA Commissioner Margaret Hamburg revoked the agency's approval of the breast cancer indication for Genentech Inc.'s Avastin. Read More
Caloric restriction doesn't just extend the life span of people. Bacteria can become all-but-impervious to antibiotics when nutrients are limited – a phenomenon that is known as tolerance, to distinguish it from resistance, which is caused by mutations. Tolerance is particularly pronounced in biofilms, bacterial films, which are a problem on medical devices from catheters to hip implants. Read More
Through a process of business combination, restructuring, refocusing and a change in leadership, the entity formerly known as Biocontrol Ltd., of London, has emerged as a new company based in the U.S. called AmpliPhi Biosciences Corp. Read More
• Coronado Biosciences Inc., of Burlington, Mass., said its common stock was approved for listing on the OTC Bulletin Board. The company went public via the alternate Form 10 pathway. Its shares (OTCQB:CNDO) closed at $10 Friday, down $1. Read More
• Tonix Pharmaceuticals Holding Corp., of New York, said the FDA cleared its investigational new drug application for a comparative pharmacokinetic and bioavailability study of TNX-102, an oral formulation of cyclobenzaprine for treating fibromyalgia syndrome. Read More
Hydrogen sulfide is a gas that, much like nitric oxide, functions as a signaling molecule in mammals. Now, scientists from New York University Medical School have found that bacteria, too, use hydrogen sulfide – to protect themselves against antibiotics. Read More
